- The Site is maintained and operated by a third-party vendor, Citrix Systems, Inc. (the “Vendor”), a company that is not affiliated with Ingalls & Snyder, LLC (“Ingalls”). While Ingalls has selected the Vendor based on its belief that the Vendor has commercially reasonable safeguards designed to (i) ensure the security and confidentiality of any non-public information (“Information”) transmitted using the Site, (ii) protect against any anticipated threats or hazards to the security or integrity of Information transmitted using the Site and (iii) protect against unauthorized access to, or use of, Information transmitted using the Site, Ingalls does not exercise any control over the Vendor’s systems and cannot guarantee the privacy and security of any information you choose to transmit using the Site.
- Access to the Site is granted by Ingalls so that you may utilize the Service for your convenience at your sole discretion. Ingalls has no liability for any loss, claim, or other damage that results from unauthorized access to any Information transmitted using the Site. User is solely responsible for the security of Information stored locally on the User’s computer or device as well as any email account User may use to receive and send links to the Site to transmit or receive documents.
Geoffrey Hulme
Geoffrey Hulme is the Research Director at Ingalls and Snyder. In his role, Geoff works closely with portfolio management teams in their equity research efforts. He originally joined Ingalls in September 2025 as a research consultant.
Geoff has over 30 years’ experience as a fundamentally based investor. He has allocated capital in a variety of environments including institutional funds, a public company, and a venture capital fund. Most recently, Geoff was the CIO for an independent RIA based in Columbus, Ohio.
Prior to that, Geoff served as interim CEO at Innoviva (INVA) from 2018-2021, a NYSE-listed life science company. He joined in the wake of a successful activist campaign and reported to a new board. Today, Innoviva ($1.6B market cap) manages pharmaceutical royalties and a growing portfolio of infectious disease drugs.
He also spent 18 years at Alex Porter’s Amici Capital in various capacities, including Director of Research. While an equity generalist, Geoff opportunistically developed a value-based approach to investing in software and various parts of the internet sector in the wake of the early 2000’s tech meltdown. Inside of Amici, he founded and was the portfolio manager of LightPath Capital LP, which specialized in mid and small-cap tech companies. Geoff began his career as a research analyst at a NYC-based long/short equity hedge fund.
He earned his B.S. in Finance from Villanova. Geoff helps organize an annual stock pitching contest hosted by the Heilbrunn Center for Graham & Dodd Investing at Columbia Business School.
Ingalls & Snyder is a registered investment advisor and broker-dealer based in New York City. We provide investment management and related services to private clients and institutional investors.
Check the background of this firm on FINRA's BrokerCheck